Fred Alger Management’s Belite Bio BLTE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLTE
DGM
Fred Alger Management's BLTE Position: Q3 2026 in Review
Fred Alger Management increased its Belite Bio (BLTE) stake by 12% in Q3 2026, buying an estimated $41.6K and bringing the position to 2,375 shares worth $403K. The position accounts for ﹤0.01% of the portfolio, ranked #393.
Fred Alger Management first reported a position in BLTE in Q4 2025 and has held it in 4 quarters since. The position peaked at $12.7M in Q4 2025. 96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.
- Fred Alger Management held 2,375 shares of Belite Bio worth $403K as of Q3 2026.
- Fred Alger Management bought 256 Belite Bio shares in Q3 2026, an estimated $41.6K.
- Belite Bio made up ﹤0.01% of Fred Alger Management's portfolio in Q3 2026, its #393 holding.
- Fred Alger Management first reported a position in Belite Bio in Q4 2025 and has held it in 4 quarters since.
- Fred Alger Management's Belite Bio position peaked at $12.7M in Q4 2025.
- 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.
Based on Fred Alger Management's 13F filing for Q3 2026, filed 16 Nov 2026.